On April 26 2023, ERA4TB had it’s mid-term review by its funder, the Innovative Health…
IT SynapseSeptember 15, 2023
Between 23-28 July, the Gordon Research Conference (GRC) on Tuberculosis Drug Discovery and Development took place in…
IT SynapseAugust 4, 2023
On 5th July 2023, ERA4TB hosted a workshop at the 19th World Congress of Basic…
IT SynapseJuly 18, 2023
Over 100 project members from across Europe and the US, attended the 7th ERA4TB Consortium…
IT SynapseJune 22, 2023
More than 120 representatives of ERA4TB partners are meeting face to face with the occasion…
IT SynapseJune 17, 2022
ERA4TB announced on the 4th Consortium Meeting that CIM – Sant Pau (IIB Sant Pau)…
IT SynapseFebruary 1, 2022
Dr Gilla Kaplan, Ph.D. Former Director of the Global Health Program, Tuberculosis, at the Bill…
IT SynapseFebruary 1, 2022
On the 27th and 28th of January 2022, Consortium members gathered virtually for two days…
IT SynapseJanuary 31, 2022
TB Alliance announced that on December 1, 2020, the first dose was administered to a…
IT SynapseDecember 17, 2020
